• 

  Covishield could soon be available at medical stores as SII seeks full market authorisation nod

  India | December 31, 2021 14:12 IST

  Covishield has been one of the main Covid-19 vaccines used in India for inoculation. Around 90% population have got Covishield.

• 

  India total vaccination: 143.83 cr vaccine doses administered till December 30, 2021

  India | December 30, 2021 10:45 IST

  The Centre has ramped up door-to-door vaccination in order to achieve the target of 100 per cent vaccination of the eligible population who are supposed to receive the jab.

• 

  CDSCO panel recommends emergency use authorisation for SII’s Covovax

  India | December 28, 2021 0:00 IST

  A CDSCO panel has also recommended restricted emergency use of anti-Covid pill Molnupiravir in India.

• 

  Over 60% of India's population fully vaccinated against Covid-19

  India | December 23, 2021 12:13 IST

  The cumulative doses administered in the country so far under the nationwide COVID-19 vaccination drive has exceeded 139.70 crore.

• 

  WHO approves Covovax for emergency use: Adar Poonawalla

  India | December 17, 2021 20:53 IST

  The DCGI office had granted SII permission to manufacture and stock Covovax on May 17.

• 

  Vaccine for children aged 3 years and above to be launched in 6 months: Serum Institute

  India | December 14, 2021 17:23 IST

  Speaking about the Omicron variant, Poonawalla said, "On the back of enough data, it is safe to say that booster vaccine doses are a proven strategy to get antibodies up to a great extent".

• 

  Expert panel to meet today over Covid booster shot amid Omicron threat

  India | December 10, 2021 9:14 IST

  A booster dose of COVID-19 vaccines, administered months after primary vaccination, is expected to augment immunity against the virus, including neutralizing capacity against the 'variants of concern'.

• 

  Serum Institute seeks Covishield's booster dose approval from DCGI

  India | December 01, 2021 23:56 IST

  In an application to the Drugs Controller General of India (DCGI), Prakash Kumar Singh, the Director, Government and Regulatory Affairs at Serum Institute of India (SII) cited that the UK's Medicines and Healthcare products Regulatory Agency has already approved the booster dose of AstraZeneca.

• 

  Will current vaccines remain effective against Omicron? Drugmakers explain

  India | December 02, 2021 16:52 IST

  With Omicron raising concerns about Covid vaccines' efficacy, drugmakers are stress-testing existing jabs while also racing to prepare new formulas.

• 

  Serum Institute resumes exports of Covishield vaccine

  India | November 26, 2021 18:23 IST

  The vaccine maker has cumulatively produced 1.25 billion doses of COVID-19 vaccines so far, a company statement said.

• 

  Government allows Serum Institute to export 50 lakh Covishield doses under COVAX to 4 nations

  India | November 21, 2021 21:36 IST

  The government, earlier in October, had permitted the SII to export 10 lakh Covishield doses each to Nepal, Myanmar, and Bangladesh under the 'Vaccine Maitri' program.

Advertisement
• 

  Over 109 crore Covid vaccine doses administered in country so far: Mansukh Mandaviya

  India | November 09, 2021 17:24 IST

  The Union Health Minister also informed that under 'Har ghar dastak', healthcare workers are going to all houses to carry out the vaccination drive. 96 countries have recognised Covaxin & Covishield. People can see the list via CoWIN app.

• 

  Serum Institute seeks regular marketing authorisation from DCGI for Covishield

  India | October 25, 2021 21:51 IST

  If the DCGI grants regular marketing authorisation, Covishield will be the second vaccine in the world to receive such approval. Pfizer-BioNTech's COVID-19 vaccine has received full US FDA approval for use in individuals 16 years of age and older.

• 

  'I got Covishield from India': President of the 76th UN General Assembly Abdulla Shahid

  World | October 02, 2021 14:24 IST

  The Covishield vaccine, which has been developed by British-Swedish pharmaceutical company AstraZeneca, is manufactured in India by Pune-based Serum Institute of India.

• 

  Centre got over 65.25 crore Covishield doses, 9.1 crore Covaxin jabs till September 19

  India | October 01, 2021 17:36 IST

  SII has supplied 20.29 lakh doses of Covishield to Health Ministry in Sept as committed in Aug by Prakash Singh, Director, Govt and Regulatory Affairs at the Pune-based firm.

• 

  Thane: Man given anti-rabies shot instead of Covid vaccine

  India | September 29, 2021 9:37 IST

  A man in Thane was mistakenly given an anti-rabies shot instead of Covid vaccine at a health centre.

• 

  COVID-19 vaccine certification for travel must meet ‘minimum criteria’: UK

  World | September 23, 2021 17:57 IST

  Travellers who are not fully vaccinated, or vaccinated in a country such as India currently not on the UK government’s recognised list, must take a pre-departure test, pay for day two and day eight PCR tests after arrival in England and self-isolate for 10 days, with an option to "test to release" after five days following a negative PCR test.

• 

  Not aware of any concerns being raised by UK: NHA CEO on Covid vaccine certification issue

  India | September 22, 2021 21:07 IST

  India had on Tuesday warned of "reciprocal measures" if the UK does not address its concerns over the new travel rules relating to COVID-19 vaccine certification with Foreign Secretary Harsh Vardhan Shringla describing these norms as "discriminatory".

• 

  After India's strong protest, UK now qualifies Covishield as approved Covid-vaccine

  India | September 22, 2021 17:40 IST

  India on Tuesday had warned of "reciprocal measures" if the UK does not address its concerns over the new travel rules relating to COVID-19 vaccine certification with Foreign Secretary Harsh Vardhan Shringla describing these norms as "discriminatory".

• 

  India raises concern over UK's non-recognition of Covishield, says its ‘discriminating policy’

  India | September 21, 2021 21:20 IST

  Official sources said India will take reciprocal measures against travellers from the UK if its concerns are not addressed by October 4 when the new rules will come into effect.